Microbix Biosystems (TSE:MBX) Stock Price Crosses Above 50-Day Moving Average – Should You Sell?

Microbix Biosystems Inc. (TSE:MBX)’s stock price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$0.23 and traded as high as C$0.26. Microbix Biosystems shares last traded at C$0.23, with a volume of 106,000 shares.

Microbix Biosystems Price Performance

The company’s fifty day moving average price is C$0.23 and its 200 day moving average price is C$0.24. The company has a debt-to-equity ratio of 30.47, a quick ratio of 5.57 and a current ratio of 7.51. The firm has a market capitalization of C$31.87 million, a price-to-earnings ratio of -7.67 and a beta of 0.40.

Microbix Biosystems (TSE:MBX) last announced its quarterly earnings data on Thursday, February 12th. The company reported C($0.01) earnings per share for the quarter. Microbix Biosystems had a negative net margin of 25.48% and a negative return on equity of 14.88%. The business had revenue of C$4.22 million for the quarter. Equities research analysts expect that Microbix Biosystems Inc. will post 0.02 earnings per share for the current year.

About Microbix Biosystems

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.